<DOC>
	<DOCNO>NCT00709345</DOCNO>
	<brief_summary>This study evaluate effectiveness cognitive behavioral treatment reduce significant medical risk factor often associate people serious mental illness take atypical antipsychotic medication .</brief_summary>
	<brief_title>Behavioral Intervention Reduce Novel Antipsychotic Medication Health Risks</brief_title>
	<detailed_description>Serious mental illness encompasses large range symptom vary severity , generally include symptom describe positive negative . Positive symptom include confused thinking , delusion , hallucination , negative symptom include lack emotion depression . Because novel atypical antipsychotic medication target positive negative symptom few side effect medication , make current standard care treatment many mental illness . However , grow concern psychiatric benefit associate atypical antipsychotic medication offset serious negative medical consequence , include weight gain , obesity-related cardiovascular risk , insulin resistance , diabetes . Behavioral intervention aim help people cop serious mental illness reduce weight , sustain weight loss , achieve good fitness may improve risk/benefit ratio atypical antipsychotic medication . A small-group cognitive behavioral intervention provide peer structural risk-reduction support may beneficial mean promote healthy eating exercise habit people serious mental illness live group home . This study evaluate effectiveness small-group cognitive behavioral intervention conduct group home reduce significant medical risk factor often associate people serious mental illness take atypical antipsychotic medication . Participation study last 18 month follow-up . All participant undergo baseline assessment include follow : measurement diet exercise pattern , use self-report observational method ; measurement weight , body mass index , body fat distribution , pulse rate , blood pressure ; blood draw ; question psychological well-being quality life . Group home assign randomly provide participate resident either cognitive behavioral intervention time-matched attention control program . Participants group receive 26 weekly 1-hour small-group session 26 weekly 30-minute individual session study facilitator . The cognitive behavioral session focus promote healthy behavior , diet , exercise . The time-matched attention control session focus improve communication , develop healthy technique cop stress , resolve conflict . After complete treatment , participant receive 6 monthly 1-hour booster session assign treatment . They also repeat baseline assessment 3 time follow 12 month .</detailed_description>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Resides one designate group home Sufficiently impair psychiatric illness , reflect mental status inform judgment study participation assure time study entry Medical contraindication study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Antipsychotic Medications</keyword>
	<keyword>Behavioral Interventions</keyword>
</DOC>